Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

@article{Andriole2012ProstateCS,
  title={Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.},
  author={G. Andriole and E. Crawford and R. Grubb and S. Buys and D. Chia and T. Church and M. Fouad and C. Isaacs and P. Kvale and D. Reding and J. Weissfeld and L. Yokochi and B. O'Brien and L. Ragard and J. Clapp and Joshua M. Rathmell and T. Riley and A. Hsing and G. Izmirlian and P. Pinsky and B. Kramer and A. B. Miller and J. Gohagan and P. Prorok},
  journal={Journal of the National Cancer Institute},
  year={2012},
  volume={104 2},
  pages={
          125-32
        }
}
BACKGROUND The prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial was undertaken to determine whether there is a reduction in prostate cancer mortality from screening using serum prostate-specific antigen (PSA) testing and digital rectal examination (DRE). Mortality after 7-10 years of follow-up has been reported previously. We report extended follow-up to 13 years after the trial. METHODS A total of 76 685 men, aged 55-74 years, were enrolled at… Expand
941 Citations
Evidence-Based Versus Personalized Prostate Cancer Screening: Using Baseline Prostate-Specific Antigen Measurements to Individualize Screening.
  • S. Loeb
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2016
  • 9
Lethal Prostate Cancer in the PLCO Cancer Screening Trial.
  • 6
Prostate Cancer Screening
Risk stratification in prostate cancer screening
  • 28
Prostate-specific antigen-based screening: controversy and guidelines
  • 70
Should all colorectal cancer patients over age 60 be screened for prostate cancer?
  • Highly Influenced
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 31 REFERENCES
Mortality results from a randomized prostate-cancer screening trial.
  • 2,630
  • PDF
Screening and prostate-cancer mortality in a randomized European study.
  • 2,262
  • PDF
Comorbidity and mortality results from a randomized prostate cancer screening trial.
  • E. Crawford, R. Grubb, +5 authors A. D'Amico
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2011
  • 147
  • PDF
Prostate-cancer screening.
  • 11
  • PDF
Screening for prostate cancer.
  • 505
Radical prostatectomy versus watchful waiting in early prostate cancer.
  • P. Walsh
  • Medicine
  • The Journal of urology
  • 2005
  • 781
  • PDF
...
1
2
3
4
...